167 related articles for article (PubMed ID: 26516900)
1. Requirements within the Ebola Viral Glycoprotein for Tetherin Antagonism.
Vande Burgt NH; Kaletsky RL; Bates P
Viruses; 2015 Oct; 7(10):5587-602. PubMed ID: 26516900
[TBL] [Abstract][Full Text] [Related]
2. Ebola Virus Glycoprotein Promotes Enhanced Viral Egress by Preventing Ebola VP40 From Associating With the Host Restriction Factor BST2/Tetherin.
Gustin JK; Bai Y; Moses AV; Douglas JL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S181-90. PubMed ID: 25821226
[TBL] [Abstract][Full Text] [Related]
3. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
[TBL] [Abstract][Full Text] [Related]
4. Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts.
Lopez LA; Yang SJ; Exline CM; Rengarajan S; Haworth KG; Cannon PM
J Virol; 2012 May; 86(10):5467-80. PubMed ID: 22398279
[TBL] [Abstract][Full Text] [Related]
5. The Tetherin Antagonism of the Ebola Virus Glycoprotein Requires an Intact Receptor-Binding Domain and Can Be Blocked by GP1-Specific Antibodies.
Brinkmann C; Nehlmeier I; Walendy-Gnirß K; Nehls J; González Hernández M; Hoffmann M; Qiu X; Takada A; Schindler M; Pöhlmann S
J Virol; 2016 Dec; 90(24):11075-11086. PubMed ID: 27707924
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of the Ebola Virus Proteins VP40 and GP
Rizk MG; Basler CF; Guatelli J
J Virol; 2017 Nov; 91(22):. PubMed ID: 28878074
[TBL] [Abstract][Full Text] [Related]
7. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.
Kaletsky RL; Francica JR; Agrawal-Gamse C; Bates P
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2886-91. PubMed ID: 19179289
[TBL] [Abstract][Full Text] [Related]
8. Ebola virus glycoprotein counteracts BST-2/Tetherin restriction in a sequence-independent manner that does not require tetherin surface removal.
Lopez LA; Yang SJ; Hauser H; Exline CM; Haworth KG; Oldenburg J; Cannon PM
J Virol; 2010 Jul; 84(14):7243-55. PubMed ID: 20444895
[TBL] [Abstract][Full Text] [Related]
9. Analysis of determinants in filovirus glycoproteins required for tetherin antagonism.
Gnirß K; Fiedler M; Krämer-Kühl A; Bolduan S; Mittler E; Becker S; Schindler M; Pöhlmann S
Viruses; 2014 Apr; 6(4):1654-71. PubMed ID: 24721789
[TBL] [Abstract][Full Text] [Related]
10. Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison JH; Guevara RB; Marcano AC; Saenz DT; Fadel HJ; Rogstad DK; Poeschla EM
J Virol; 2014 Mar; 88(6):3255-72. PubMed ID: 24390322
[TBL] [Abstract][Full Text] [Related]
11. The Ebola virus glycoprotein and HIV-1 Vpu employ different strategies to counteract the antiviral factor tetherin.
Kühl A; Banning C; Marzi A; Votteler J; Steffen I; Bertram S; Glowacka I; Konrad A; Stürzl M; Guo JT; Schubert U; Feldmann H; Behrens G; Schindler M; Pöhlmann S
J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S850-60. PubMed ID: 21987761
[TBL] [Abstract][Full Text] [Related]
12. Single Amino Acid Substitution N659D in HIV-2 Envelope Glycoprotein (Env) Impairs Viral Release and Hampers BST-2 Antagonism.
Dufrasne FE; Lombard C; Goubau P; Ruelle J
Viruses; 2016 Oct; 8(10):. PubMed ID: 27754450
[TBL] [Abstract][Full Text] [Related]
13. BST2/Tetherin enhances entry of human cytomegalovirus.
Viswanathan K; Smith MS; Malouli D; Mansouri M; Nelson JA; Früh K
PLoS Pathog; 2011 Nov; 7(11):e1002332. PubMed ID: 22072961
[TBL] [Abstract][Full Text] [Related]
14. HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway.
Liu Y; Li M; Zhang D; Zhang M; Hu Q
Virol J; 2016 Sep; 13(1):154. PubMed ID: 27630089
[TBL] [Abstract][Full Text] [Related]
15. Vpu-mediated tetherin antagonism of ongoing HIV-1 infection in CD4(+) T-cells is not directly related to the extent of tetherin cell surface downmodulation.
Kuhl BD; Sloan RD; Donahue DA; Liang C; Wainberg MA
Virology; 2011 Sep; 417(2):353-61. PubMed ID: 21757214
[TBL] [Abstract][Full Text] [Related]
16. Feline tetherin is characterized by a short N-terminal region and is counteracted by the feline immunodeficiency virus envelope glycoprotein.
Celestino M; Calistri A; Del Vecchio C; Salata C; Chiuppesi F; Pistello M; Borsetti A; Palù G; Parolin C
J Virol; 2012 Jun; 86(12):6688-700. PubMed ID: 22514338
[TBL] [Abstract][Full Text] [Related]
17. The tetherin/BST-2 coiled-coil ectodomain mediates plasma membrane microdomain localization and restriction of particle release.
Hammonds J; Ding L; Chu H; Geller K; Robbins A; Wang JJ; Yi H; Spearman P
J Virol; 2012 Feb; 86(4):2259-72. PubMed ID: 22130541
[TBL] [Abstract][Full Text] [Related]
18. The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activity.
Lemaître C; Harper F; Pierron G; Heidmann T; Dewannieux M
J Virol; 2014 Dec; 88(23):13626-37. PubMed ID: 25210194
[TBL] [Abstract][Full Text] [Related]
19. Release of Immunomodulatory Ebola Virus Glycoprotein-Containing Microvesicles Is Suppressed by Tetherin in a Species-Specific Manner.
Nehls J; Businger R; Hoffmann M; Brinkmann C; Fehrenbacher B; Schaller M; Maurer B; Schönfeld C; Kramer D; Hailfinger S; Pöhlmann S; Schindler M
Cell Rep; 2019 Feb; 26(7):1841-1853.e6. PubMed ID: 30759394
[TBL] [Abstract][Full Text] [Related]
20. Early Vertebrate Evolution of the Host Restriction Factor Tetherin.
Heusinger E; Kluge SF; Kirchhoff F; Sauter D
J Virol; 2015 Dec; 89(23):12154-65. PubMed ID: 26401043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
